Oncotarget

Vol 12, No 11

May 25, 2021

View Archive »

Order a Reprint

About The Cover

The cover for issue 11 of Oncotarget features Figure 2, "Frequency of elevated CEA according to disease status of SCCA," by Hester, et al.

Table of Contents

News

FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?

FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?

https://doi.org/10.18632/oncotarget.27957

Leandro H. Gallo
1026-1028
PDF  |  How to cite  |  Order a Reprint

Editorial

Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response

Advances in innovative exosome-technology for real time monitoring of viable drugs in clinical translation, prognosis and treatment response

https://doi.org/10.18632/oncotarget.27927

Mujib Ullah, Nicole Pek Min Qian,  and Gustavo Yannarelli
1029-1031
PDF  |  How to cite  |  Order a Reprint

Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?

https://doi.org/10.18632/oncotarget.27931

Alexander J. Bridges, Ranjit K. Mehta, Sushmita Shukla, Matthew J. Schipper, Theodore S. Lawrence,  and Mukesh K. Nyati
1032-1036
PDF  |  How to cite  |  Order a Reprint

Research Papers

CEA as a blood-based biomarker in anal cancer

CEA as a blood-based biomarker in anal cancer

https://doi.org/10.18632/oncotarget.27959

Robert Hester, Shailesh Advani, Asif Rashid, Emma Holliday, Craig Messick, Prajnan Das, Yi-Qian N. You, Cullen Taniguchi, Eugene J. Koay, Brian Bednarski, Miguel Rodriguez-Bigas, John Skibber, Robert Wolff, George J. Chang, Bruce D. Minsky, Wai Chin Foo, Nicole Rothschild, Van K. Morris,  and Cathy Eng
1037-1045
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab

Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab

https://doi.org/10.18632/oncotarget.27965

Samantha Epistolio, Marco Cefalì, Paolo Spina, Francesca Molinari, Alessandra Movilia, Massimiliano Cergnul, Luca Mazzucchelli, Sara De Dosso, Milo Frattini,  and Piercarlo Saletti
1046-1056
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma

Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma

https://doi.org/10.18632/oncotarget.27964

Chiara Colarusso, Michela Terlizzi, Anne-Sophie Lamort, Ida Cerqua, Fiorentina Roviezzo, Georgios Stathopoulos, Aldo Pinto,  and Rosalinda Sorrentino
1057-1071
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation

A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation

https://doi.org/10.18632/oncotarget.27962

Esther Baruch, Tali Nizri-Megnaji, Oron Berkowitz,  and Doron Ginsberg
1072-1082
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network

Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network

https://doi.org/10.18632/oncotarget.27963

Shweta Kishor Sonawane,  and Subashchandrabose Chinnathambi
1083-1099
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma

Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma

https://doi.org/10.18632/oncotarget.27961

Rami Mäkelä, Ville Härmä, Nibal Badra Fajardo, Greg Wells, Zoi Lygerou, Olle Sangfelt, Juha Kononen,  and Juha K. Rantala
1100-1109
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reviews

Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment

Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment

https://doi.org/10.18632/oncotarget.27929

Khoa Nguyen, Andrew Rivera, Madlin Alzoubi, Henri Wathieu, Shengli Dong, Hassan Yousefi, Margarite Matossian, Suresh Alahari, David Drewry, Matthew Burow,  and Bridgette Collins-Burow
1110-1115
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Case Reports

Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review

https://doi.org/10.18632/oncotarget.27966

Marco Rubatto, Martina Merli, Gianluca Avallone, Andrea Agostini, Luca Mastorino, Virginia Caliendo, Amelia Barcellini, Viviana Vitolo, Francesca Valvo, Maria Teresa Fierro, Simone Ribero,  and Pietro Quaglino
1116-1121
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC